Related references
Note: Only part of the references are listed.Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas
Tobias Akerstrom et al.
ENDOCRINE-RELATED CANCER (2015)
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas
Silvia Monticone et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production
Annabel Berthon et al.
HUMAN MOLECULAR GENETICS (2014)
Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma
Fabio Luiz Fernandes-Rosa et al.
HYPERTENSION (2014)
Adrenal Nodularity and Somatic Mutations in Primary Aldosteronism: One Node Is the Culprit?
T. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Route, mechanism, and implications of proton import during Na+/K+ exchange by native Na+/K+-ATPase pumps
Natascia Vedovato et al.
JOURNAL OF GENERAL PHYSIOLOGY (2014)
Development of monoclonal antibodies against human CYP11B1 and CYP11B2
Celso E. Gomez-Sanchez et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
Gerald Goh et al.
NATURE GENETICS (2014)
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
Felix Beuschlein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome
Yanan Cao et al.
SCIENCE (2014)
Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome
Yusuke Sato et al.
SCIENCE (2014)
Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study
Sebastien Savard et al.
HYPERTENSION (2013)
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Elena A. B. Azizan et al.
NATURE GENETICS (2013)
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism
Ute I. Scholl et al.
NATURE GENETICS (2013)
Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin
Joanne H. Heaton et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies
A. Hannemann et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Microarray, qPCR, and KCNJ5 Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumors
Elena A. B. Azizan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter
Tobias Akerstrom et al.
PLOS ONE (2012)
Aldosterone-Producing Adenoma Formation in the Adrenal Cortex Involves Expression of Stem/Progenitor Cell Markers
Sheerazed Boulkroun et al.
ENDOCRINOLOGY (2011)
Characterization of Differential Gene Expression in Adrenocortical Tumors Harboring β-Catenin (CTNNB1) Mutations
Julien Durand et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Constitutive β-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development
Annabel Berthon et al.
HUMAN MOLECULAR GENETICS (2010)
A Two-Step Model for Colon Adenoma Initiation and Progression Caused by APC Loss
Reid A. Phelps et al.
CELL (2009)
Wnt signaling: the good and the bad
Xi Chen et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2008)
Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex
Alex C. Kim et al.
DEVELOPMENT (2008)
Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase a signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors
Sebastien Gaujoux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients
Peyman Bjorklund et al.
MOLECULAR CANCER (2008)
Wnt3a binds to several sFRPs in the nanomolar range
Danuta Wawrzak et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Prevalence of primary aldosteronism among unselected hypertensive patients: A prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test
Roberto Fogari et al.
HYPERTENSION RESEARCH (2007)
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Gian Paolo Rossi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I
M Stowasser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mutations of β-catenin in adrenocortical tumors:: Activation of the wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors
F Tissier et al.
CANCER RESEARCH (2005)
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
P Milliez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Extensive personal experience - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
P Mulatero et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas
F Fallo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production
M Heikkilä et al.
ENDOCRINOLOGY (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Share Paper
